1,473
Views
5
CrossRef citations to date
0
Altmetric
HEMATOLOGICAL MALIGNANCY

The level of peripheral blood circulating CD34+ cells is higher in acute promyelocytic leukemia patients with adverse prognostic factors

, , , , , & show all

References

  • Ahmad EI, Akl HKh, Hashem ME, Elgohary TA. The biological characteristics of adult CD34+ acute promyelocytic leukemia. Med Oncol 2012;29(2):1119–26. doi: 10.1007/s12032-011-9895-y
  • Wagner-Souza K, Diamond HR, Ornellas MH, Gomes BE, Almeida-Oliveira A, Abdelhay E, et al. Rhodamine 123 efflux in human subpopulations of hematopoietic stem cells: comparison between bone marrow, umbilical cord blood and mobilized peripheral blood CD34+ cells. Int J Mol Med 2008;22(2):237–42.
  • Chicha L, Feki A, Boni A, Irion O, Hovatta O, Jaconi M. Human pluripotent stem cells differentiated in fully defined medium generate hematopoietic CD34– and CD34+ progenitors with distinct characteristics. PLoS One. 2011;6(2):e14733. doi: 10.1371/journal.pone.0014733
  • Guan CY, Zhang QG, OuYang J, Zhou RF, Zeng H, Li P, et al. The clinical significance of circulating CD34+ cells in myelodysplastic syndrome and acute leukemia. Acta Universitatis Medicinalis Nanjing (Natural Science) 2010;30(6):847–49.
  • Passamonti F, Vanelli L, Malabarba L, Rumi E, Pungolino E, Malcovati L, et al. Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders. Haematologica. 2003;88(10):1123–9.
  • Alchalby H, Lioznov M, Fritzsche-Friedland U, Badbaran A, Zabelina T, Bacher U, et al. Circulating CD34(+) cells as prognostic and follow-up marker in patients with myelofibrosis undergoing allo-SCT. Bone Marrow Transplant  2012;47(1):143–5. doi: 10.1038/bmt.2011.17
  • Zeng H, Zhang QG, OuYang J, Guan CY, Li P, Chen B, et al. The enumeration of circulating CD34+ cells in myeloproliferative neoplasms and its clinical significance. Jiangsu Med J 2014;40(13):1550–2.
  • Fuchigami K, Mori H, Matsuo T, Iwanaga M, Nagai K, Kuriyama K, et al. Absolute number of circulating CD34 cells is abnormally low in refractory anemias and extremely high in RAEB and RAEB-t; novel pathologic features of myelodysplastic syndromes identified by highly sensitive flow cytometry. Leuk Res 2000;24(2):163–74. doi: 10.1016/S0145-2126(99)00167-8
  • Braulke F, Schanz J, Jung K, Shirneshan K, Schulte K, Schuetze C, et al. FISH analysis of circulating CD34+ cells as a new tool for genetic monitoring in MDS: verification of the method and application to 27 MDS patients. Leuk Res 2010;34(10):1296–301. doi: 10.1016/j.leukres.2010.01.010
  • Zeng H, Zhang QG, OuYang J, Xu JY, Li P, Guan CY, et al. Analysis of circulating CD34+ cells in the peripheral blood in pancytopenia. Chin J Clin (Electron Ed) 2013;7(11):5071–3.
  • Kelaidi C, Adès L, Fenaux P. Treatment of acute promyelocytic leukemia with high white cell blood counts. Mediterr J Hematol Infect Dis 2011;3(1):e2011038. doi: 10.4084/mjhid.2011.038
  • Chillón MC, Santamaría C, García-Sanz R, Balanzategui A, Sarasquete ME, Alcoceba M, et al. Long FLT3 internal tandem duplications and reduced PML/RARa expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients. Haematologica 2010;95(5):745–51. doi: 10.3324/haematol.2009.015073
  • Xu F, Yin CX, Wang CL, Jiang XJ, Jiang L, Wang ZX, et al. Immunophenotypes and immune markers associated with acute promyelocytic leukemia prognosis. Dis Markers 2014;2014:421906.
  • Alhan C, Westers TM, Ossenkopple GJ, van de Loosdrecht AA. Do peripheral blasts count in myelodysplastic syndromes? Leuk Res 2009;33(2):209–11. doi: 10.1016/j.leukres.2008.06.015
  • Sullivan SA, Marsden KA, Lowenthal RM, Jupe DM, Jones ME. Circulating CD34+ cells: an adverse prognostic factor in the myelodysplastic syndromes. Am J Hematol 1992;39(2):96–101. doi: 10.1002/ajh.2830390205
  • Cesana C, Klersy C, Brando B, Nosari A, Scarpati B, Scampini L, et al. Prognostic value of circulating CD34+ cells in myelodysplastic syndromes. Leuk Res 2008;32(11):1715–23. doi: 10.1016/j.leukres.2008.03.028
  • Knipp S, Strupp C, Gatterman N, Hildebrandt B, Schapira M, Giagounidis A, et al. Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome. Leuk Res 2008;32(1):33–7. doi: 10.1016/j.leukres.2007.02.021

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.